Let me just say it: if you're a procurement manager in healthcare and you only look at orthopedic implants or dental products when evaluating a company like Zimmer Biomet, you're missing half the picture. I learned this the hard way.
When I first started managing our medical device contracts—this was back in 2021—I assumed my job was simple: find the best price on implants, instruments, and maybe a surgical robot if we were feeling ambitious. I thought electric wheelchairs, AEDs (defibrillators), and nuclear medicine had nothing to do with me. Boy, was I wrong.
What I Initially Got Wrong About "Core Products"
My initial approach to vendor evaluation was completely focused on the obvious stuff. Zimmer Biomet is known for hips, knees, dental implants, and the ROSA robot. So that's all I tracked. I figured everything else was someone else's problem.
Three years and two budget overruns later, I realized: the "ancillary" equipment is where the hidden costs—and hidden value—live.
Here's what changed my mind:
Electric Wheelchairs and Mobility: The Patient Care Continuum
We ordered a batch of bariatric electric wheelchairs for our rehab wing in Q2 2023. Nothing fancy—just standard models. The vendor we used was not Zimmer Biomet. But here's what I didn't connect at the time: a patient who gets a Zimmer Biomet hip replacement and then needs a wheelchair for recovery? That's a single patient journey. If the wheelchair vendor doesn't coordinate with the implant team, you get mismatched specifications (like weight limits or seat dimensions that don't fit post-op protocols).
I remember thinking, "Why would a wheelchair vendor need to talk to an implant vendor?" Then we had a patient whose post-op wheelchair couldn't accommodate their new hip's range of motion—a $900 return, $450 in restocking fees, and a week of delayed discharge. That's real money, (ugh).
Zimmer Biomet doesn't make wheelchairs, but the ecosystem matters. When you evaluate a partner, you need to ask: "How does your implant connect to the rest of the patient's mobility journey?" That question saved us about $8,400 annually once we started coordinating specs across vendors.
Defibrillator AED: Not Just a Safety Checkbox
I used to think AEDs were just compliance items—buy the cheapest one, pass the inspection, move on. Then I sat in on a clinical training session Zimmer Biomet offered (I think it was part of their medical education program). The trainer spent 20 minutes explaining how AED placement and response times affect surgical outcomes in orthopedic procedures—especially for older patients or those with cardiac risk factors.
Frankly, I felt stupid. We had 12 AEDs across our facility, all from different vendors, with inconsistent maintenance contracts. One was out of battery during an inspection (that was fun to explain). If I had considered the defibrillator—or rather, the integration of emergency response with surgical planning—I would have had a stronger case for a bundled contract.
Now? Every device contract I negotiate includes a clause about emergency equipment compatibility. Sounds overkill? It's not. It's about TCO (total cost of ownership). A $200 savings on an AED can cost you $1,200 in rework if it fails during a critical moment.
Nuclear Medicine: The Unseen Diagnostic Layer
Here's where it gets really interesting. What is nuclear medicine? Honestly, I didn't know until about 18 months ago. I thought it was some specialized imaging thing that had nothing to do with orthopedic procurement.
Turns out, nuclear medicine (like bone scans and PET scans) is directly relevant to implant planning. Orthopedic surgeons use nuclear imaging to assess bone health, infection, and implant integration. If the imaging equipment isn't calibrated correctly—or if the vendor doesn't coordinate with the implant supplier—you get misdiagnoses, delayed surgeries, or even implant revision costs.
I discovered this when we had a patient whose pre-surgery bone scan (done on non-Zimmer Biomet equipment) suggested poor bone density. The surgeon postponed the procedure. Three weeks later, a second scan showed normal results. The first machine was miscalibrated. That cost us about $4,200 in rescheduling and wasted prep time.
So now, when I evaluate Zimmer Biomet—or any implant vendor—I ask: "Who provides your diagnostic imaging? How do you ensure calibration consistency across facilities?" If they can't answer, that's a red flag.
The Argument I Know You're Thinking: "That's Not My Job"
I can hear the pushback: "I'm a procurement manager, not a radiologist. Why should I care about nuclear medicine?" Fair point. But here's the thing: the boundaries between categories are artificial. The patient doesn't experience "implant procurement" and "wheelchair procurement" as separate events. They experience care. If you only manage your line item, you're leaving money—and risk—on the table.
Another objection: "But Zimmer Biomet doesn't make AEDs or wheelchairs." True. But the clinical research and medical education they provide covers these topics. Their training programs (which I've attended) explicitly discuss how these technologies interact. If you're not listening to that part of their offering, you're ignoring a major value-add.
What Hasn't Changed: The Fundamentals of Good Procurement
I don't want to sound like everything has changed. Some things haven't:
- You still need competitive quotes (I require 3 minimum).
- You still need to check for hidden fees (setup, calibration, training).
- You still need to track reliability over time (our system tracks 6 years of data).
But what was best practice in 2020 may not apply in 2025. The old approach was "buy the implant from the implant vendor, buy the wheelchair from the wheelchair vendor, and never the twain shall meet." That's outdated.
The best procurement managers I know now think in patient journeys, not product categories. That's the evolution.
Bottom Line
If you're evaluating Zimmer Biomet—or any major medical device supplier—don't just look at their core products. Look at:
- Their clinical research on what is nuclear medicine and how it affects implant outcomes
- Their defibrillator (AED) integration protocols (or lack thereof)
- Their approach to mobility equipment (like electric wheelchairs) as part of the care continuum
The companies that bundle knowledge, not just products? Those are the ones that save you money in the long run. It took me 4 years and about 200 orders to figure that out. Hope this saves you some time—and some budget overruns.
Leave a Reply